| Home > Publications Database > A total of 220 patients with autosomal dominant spastic paraplegia do not display mutations in the SLC33A1 gene (SPG42). > print |
| 001 | 136093 | ||
| 005 | 20240324002843.0 | ||
| 024 | 7 | _ | |a 10.1038/ejhg.2010.68 |2 doi |
| 024 | 7 | _ | |a pmid:20461110 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC2987419 |2 pmc |
| 024 | 7 | _ | |a 1018-4813 |2 ISSN |
| 024 | 7 | _ | |a 1476-5438 |2 ISSN |
| 024 | 7 | _ | |a altmetric:126687336 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-02415 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Schlipf, Nina A |0 P:(DE-HGF)0 |b 0 |
| 245 | _ | _ | |a A total of 220 patients with autosomal dominant spastic paraplegia do not display mutations in the SLC33A1 gene (SPG42). |
| 260 | _ | _ | |a Basingstoke |c 2010 |b Stockton Press |
| 264 | _ | 1 | |3 online |2 Crossref |b Springer Science and Business Media LLC |c 2010-05-12 |
| 264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2010-09-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1588685327_1066 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a The most frequent causes of autosomal dominant (AD) hereditary spastic paraplegias (HSP) (ADHSP) are mutations in the SPAST gene (SPG4 locus). However, roughly 60% of patients are negative for SPAST mutations, despite their family history being compatible with AD inheritance. A mutation in the gene for an acetyl-CoA transporter (SLC33A1) has recently been reported in one Chinese family to cause ADHSP-type SPG42. In this study, we screened 220 independent SPAST mutation-negative ADHSP samples for mutations in the SLC33A1 gene by high-resolution melting curve analysis. Conspicuous samples were validated by direct sequencing. Moreover, copy number variations affecting SLC33A1 were screened by multiplex ligation-dependent probe amplification assay. We could not identify potentially disease-causing mutations in our patients either by mutation scanning or by gene dosage analysis, as for the latter specific positive controls are not available to date. As our sample represents ADHSP patients for whom SPAST mutations and almost in all cases ATL1 and REEP1 mutations had been excluded, we consider SLC33A1 gene mutations as being very rare in a European ADHSP cohort, if present at all. To date, as SPG42 has still not been identified in a second, unrelated family, systematic genetic testing for SLC33A1 mutations is not recommended. |
| 536 | _ | _ | |a 344 - Clinical and Health Care Research (POF3-344) |0 G:(DE-HGF)POF3-344 |c POF3-344 |f POF III |x 0 |
| 536 | _ | _ | |a 345 - Population Studies and Genetics (POF3-345) |0 G:(DE-HGF)POF3-345 |c POF3-345 |f POF III |x 1 |
| 542 | _ | _ | |i 2010-05-12 |2 Crossref |u http://www.springer.com/tdm |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a Membrane Transport Proteins |2 NLM Chemicals |
| 650 | _ | 7 | |a SLC33A1 protein, human |2 NLM Chemicals |
| 650 | _ | 2 | |a Genes, Dominant |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Membrane Transport Proteins: genetics |2 MeSH |
| 650 | _ | 2 | |a Mutation |2 MeSH |
| 650 | _ | 2 | |a Paraplegia: genetics |2 MeSH |
| 700 | 1 | _ | |a Beetz, Christian |0 P:(DE-HGF)0 |b 1 |
| 700 | 1 | _ | |a Schüle, Rebecca |0 P:(DE-2719)2812018 |b 2 |u dzne |
| 700 | 1 | _ | |a Stevanin, Giovanni |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Erichsen, Anne Kjersti |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Forlani, Sylvie |0 P:(DE-HGF)0 |b 5 |
| 700 | 1 | _ | |a Zaros, Cécile |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Karle, Kathrin |0 P:(DE-2719)9000150 |b 7 |u dzne |
| 700 | 1 | _ | |a Klebe, Stephan |0 P:(DE-HGF)0 |b 8 |
| 700 | 1 | _ | |a Klimpe, Sven |0 P:(DE-HGF)0 |b 9 |
| 700 | 1 | _ | |a Durr, Alexandra |0 P:(DE-HGF)0 |b 10 |
| 700 | 1 | _ | |a Otto, Susanne |0 P:(DE-HGF)0 |b 11 |
| 700 | 1 | _ | |a Tallaksen, Chantal M E |0 P:(DE-HGF)0 |b 12 |
| 700 | 1 | _ | |a Riess, Olaf |0 P:(DE-HGF)0 |b 13 |
| 700 | 1 | _ | |a Brice, Alexis |0 P:(DE-HGF)0 |b 14 |
| 700 | 1 | _ | |a Bauer, Peter |0 P:(DE-HGF)0 |b 15 |e Corresponding author |
| 700 | 1 | _ | |a Schöls, Ludger |0 P:(DE-2719)2810795 |b 16 |e Last author |u dzne |
| 773 | 1 | 8 | |a 10.1038/ejhg.2010.68 |b : Springer Science and Business Media LLC, 2010-05-12 |n 9 |p 1065-1067 |3 journal-article |2 Crossref |t European Journal of Human Genetics |v 18 |y 2010 |x 1018-4813 |
| 773 | _ | _ | |a 10.1038/ejhg.2010.68 |g Vol. 18, no. 9, p. 1065 - 1067 |0 PERI:(DE-600)2005160-8 |n 9 |q 18:9<1065 - 1067 |p 1065-1067 |t European journal of human genetics |v 18 |y 2010 |x 1018-4813 |
| 856 | 7 | _ | |2 Pubmed Central |u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987419 |
| 909 | C | O | |o oai:pub.dzne.de:136093 |p VDB |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2812018 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 7 |6 P:(DE-2719)9000150 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 16 |6 P:(DE-2719)2810795 |
| 913 | 1 | _ | |a DE-HGF |b Forschungsbereich Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-344 |2 G:(DE-HGF)POF3-300 |v Clinical and Health Care Research |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Forschungsbereich Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-345 |2 G:(DE-HGF)POF3-300 |v Population Studies and Genetics |x 1 |
| 914 | 1 | _ | |y 2010 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EUR J HUM GENET : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
| 920 | 1 | _ | |0 I:(DE-2719)5000024 |k AG Maetzler |l Functional Neurogeriatrics |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)5000057 |k Ext HIH |l Ext Hertie-Institut für klinische Hirnforschung |x 1 |
| 920 | 1 | _ | |0 I:(DE-2719)5000005 |k AG Schöls 1 |l Clinical Neurogenetics |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)5000024 |
| 980 | _ | _ | |a I:(DE-2719)5000057 |
| 980 | _ | _ | |a I:(DE-2719)5000005 |
| 980 | _ | _ | |a UNRESTRICTED |
| 999 | C | 5 | |a 10.1007/s11910-996-0011-1 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s11910-996-0011-1 |
| 999 | C | 5 | |a 10.1097/WCO.0b013e3282f190ba |9 -- missing cx lookup -- |2 Crossref |o 10.1097/WCO.0b013e3282f190ba |
| 999 | C | 5 | |a 10.1016/S0140-6736(83)92879-9 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S0140-6736(83)92879-9 |
| 999 | C | 5 | |a 10.1016/S1474-4422(08)70258-8 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S1474-4422(08)70258-8 |
| 999 | C | 5 | |a 10.1002/humu.9205 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/humu.9205 |
| 999 | C | 5 | |a 10.1136/jnnp.2007.137596 |9 -- missing cx lookup -- |2 Crossref |o 10.1136/jnnp.2007.137596 |
| 999 | C | 5 | |a 10.1093/brain/awn026 |9 -- missing cx lookup -- |2 Crossref |o 10.1093/brain/awn026 |
| 999 | C | 5 | |a 10.1007/s00415-006-0470-y |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s00415-006-0470-y |
| 999 | C | 5 | |a 10.1016/j.jns.2007.11.015 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.jns.2007.11.015 |
| 999 | C | 5 | |a 10.1016/j.ajhg.2008.11.003 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.ajhg.2008.11.003 |
| 999 | C | 5 | |a 10.1007/s00424-003-1071-6 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s00424-003-1071-6 |
| 999 | C | 5 | |a 10.1212/01.wnl.0000191390.20564.8e |9 -- missing cx lookup -- |2 Crossref |o 10.1212/01.wnl.0000191390.20564.8e |
| 999 | C | 5 | |a 10.1002/humu.20920 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/humu.20920 |
| 999 | C | 5 | |a 10.1136/jmg.2006.046425 |9 -- missing cx lookup -- |2 Crossref |o 10.1136/jmg.2006.046425 |
| 999 | C | 5 | |a 10.1007/s10048-008-0158-9 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s10048-008-0158-9 |
| 999 | C | 5 | |a 10.1093/nar/29.1.308 |9 -- missing cx lookup -- |2 Crossref |o 10.1093/nar/29.1.308 |
| 999 | C | 5 | |a 10.1002/humu.20951 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/humu.20951 |
| 999 | C | 5 | |a 10.1002/humu.21019 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/humu.21019 |
| 999 | C | 5 | |a 10.1212/01.wnl.0000244413.49258.f5 |9 -- missing cx lookup -- |2 Crossref |o 10.1212/01.wnl.0000244413.49258.f5 |
| 999 | C | 5 | |a 10.1373/clinchem.2009.124958 |9 -- missing cx lookup -- |2 Crossref |o 10.1373/clinchem.2009.124958 |
| 999 | C | 5 | |a 10.1038/35057062 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/35057062 |
| 999 | C | 5 | |a 10.1002/humu.20216 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/humu.20216 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|